Genomenon Webinars

Learn from the experts in genomics

LATEST WEBINAR

Locus-Specific Patient Databases for Rare Disease: A Computational Approach
Thursday, November 18, 2021

In our latest webinar, Genomenon’s Chief Science Officer, Dr. Mark Kiel was joined by Dr. Gus Khursigara, VP of Medical Affairs and Clinical Strategy at Inozyme Pharma to discuss how a computational approach to curation of medical evidence has emerged as an efficient and economical method to systematically identify and analyze all reported cases of a rare disease and interpret all associated genetic variants.

Watch the recording

LATEST WEBINAR<h5>Locus-Specific Patient Databases for Rare Disease: A Computational Approach </b><br><h6><b>Thursday, November 18, 2021 </h6></b>
DNA TODAY PODCAST | MARK KIEL ON ALS GENETICS

PHARMA

In this episode of the DNA Today podcast we explore the genetics of ALS with Mark Kiel, the Chief Science Officer of Genomenon. Watch the interview to learn more about Genomenon and the findings from their comprehensive Genomic Landscape for ALS, new data on the prevalence of gene mutations in ALS, and more.

Watch the recording

GENOMIC BIOMARKER SELECTION FOR COMPANION DIAGNOSTIC DEVELOPMENT

PHARMA

In this webinar, expert panelists from Gilead Sciences, Illumina, Loxo Oncology, and Taiho Oncology will explore the utility of comprehensive Genomic Landscapes for precision medicine in oncology. Drawing on a wealth of experience in the oncology CDx space, our speakers will highlight the current applications, upcoming trends, and future challenges of CDx development in the modern precision medicine era.

Watch the recording

VARIANT INTERPRETATION CHALLENGES & USE CASES | LEVERAGING MASTERMIND IN THE CLINICAL LAB

CLINICAL 

In this webinar, Dr. Dan Bellissimo, Director of the Clinical Genomics Laboratory at the University of Pittsburgh Medical Center (UPMC) presents a variety of clinical cases and workflows that illustrate how these variant interpretation challenges have been addressed by the Mastermind Genomic Search Engine to reduce turnaround time, increase diagnostic yield, and accelerate throughput.

Watch the recording

ESHG 2021 | CLINICAL PERSPECTIVES: OPTIMIZED VARIANT INTERPRETATION WITH THE MASTERMIND GENOMIC SEARCH ENGINE

CLINICAL 

Watch our ESHG 2021 corporate satellite presentation where Nisa Esen of Acibadem Labgen in Turkey and Ariana Gonzalez of Héritas in Argentina share real-world cases where use of the Mastermind Genomic Search Engine led to more informed diagnosis and treatment decisions.

Watch the recording

CONSOLIDATED APPROACH FOR THE INTERPRETATION OF HEREDITARY CANCER VARIANTS

CLINICAL 

In this webinar, Laura Semenuk, MSc, MLT, of Kingston Health Sciences Centre shows you how Alamut Visual Plus has the computational power to pull data sources together, allowing for a consolidated and consistent approach to genomic variant interpretation in the context of hereditary cancers.

Watch the recording

THE EMERGENCE OF AI-GUIDED GENOMICS TO ACCELERATE VARIANT INTERPRETATION

CLINICAL 

In this live expert discussion, we discussed high-level industry challenges associated with genetic variant interpretation, the emerging role of AI and machine learning-assisted technology in genomics, and recent findings surrounding the implications of novel computational genomic intelligence platforms.

Watch the recording

STREAMLINING GENETIC DIAGNOSIS AND TREATMENT PLANS FOR RARE DISORDERS AND PEDIATRIC CANCER PREDISPOSITION

CLINICAL

In this Children’s Hospital genomics roundtable discussion, experienced laboratory directors and clinicians gathered from a variety of institutions leading the charge in pediatric genomics research, including St. Jude Children’s Research Hospital, Children’s Hospital of Colorado, Nationwide Children’s Hospital, and Memorial Sloan Kettering Cancer Center.

Watch the recording

ACMG 2021 | CLINICAL PERSPECTIVES: OPTIMIZED VARIANT INTERPRETATION WITH THE MASTERMIND GENOMIC SEARCH ENGINE

CLINICAL 

At the ACMG Product Theater, Dr. Andreas Laner of MGZ Medical Genetics Center and Dr. Pippa Grainger of Auckland Hospital share real-world cases where use of the Mastermind Genomic Search Engine led to more informed diagnosis and treatment decisions.

Watch the recording

MASTERMIND MASTERCLASS: GENOMIC ASSOCIATIONS INTERFACE

CLINICAL 

In this Mastermind Masterclass webinar, Genomenon co-founders Dr. Mark Kiel and Steve Schwartz, are joined by Elizabeth Varga, Director of Customer Success, who introduced this exciting new functionality, as well as explored how Genomic Associations can best serve you and your variant interpretation goals.

Watch the recording

HOW GENETICS IS BEING USED TO DRIVE DRUG DISCOVERY & DEVELOPMENT

PHARMA

In this panel discussion, precision medicine executives from Rhythm Pharmaceuticals, Alexion, and Biogen explore the deep and invaluable connection between drug development and genomics – and how they are driving innovation with genomic knowledge within Pharma.

Watch the recording

THE COMPREHENSIVE AI-DRIVEN GENOMIC LANDSCAPE FOR ALS – IMPLICATIONS FOR DRUG DISCOVERY AND DEVELOPMENT

PHARMA

Genomenon Co-Founder and Chief Science Officer, Mark Kiel, MD, PhD, was a featured speaker at the 4th Annual Drug Discovery & Development Virtual Conference hosted by LabRoots. Dr. Kiel presented the results of Genomenon’s curation efforts and what it may mean for improving ALS diagnosis and treatment.

Watch the recording

THE CHALLENGE OF VARIANT INTERPRETATION: LEVERAGING GENETIC AND CLINICAL EVIDENCE TO IMPROVE THE DIAGNOSIS OF RARE DISEASES

CLINICAL 

In this webinar, speakers from Limbus Medical Technologies, MGZ, and Genomenon shared their perspectives on what is necessary to successfully accept challenges in clinical routine and what tools are available and needed to accelerate and improve the diagnostic process.

Watch the recording

RAPID WGS: HOW RADY CHILDREN’S INSTITUTE IS INCREASING DIAGNOSTIC YIELD AND IMPROVING OUTCOMES

CLINICAL 

Dr. Stephen Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine, gives an executive overview of the two-time world-record-setting Rady rWGS method, followed by a deeper examination of the institute’s analysis and interpretation pipeline by Dr. Katarzyna (Kasia) Ellsworth. The presentation included a demonstration of the Rady literature curation process that is powered by the Mastermind Genomic Search Engine.

Watch the recording

NSGC GENOMIC TECHNOLOGIES & HEALTH IT SIG WEBINAR SERIES: AI 101

CLINICAL 

This webinar titled, Artificial Intelligence (AI) 101, hosted by the National Society of Genetic Counselors welcomed guest speaker Dr. Mark Kiel, co-founder and Chief Science Officer at Genomenon. Attendees learned about the fundamentals of Artificial Intelligence and its implication in medical genomics—now and in the future.

Watch the recording

MASTERMIND MASTERCLASS: CNV SEARCH

CLINICAL | PHARMA

Co-founders Dr. Mark Kiel and  Steve Schwartz take a use-case approach to highlighting the new CNV capability and showcase the benefits that Mastermind can provide to cytogeneticists and variant scientists.

Watch the recording

MASTERMIND MASTERCLASS: GENOMIC ASSOCIATIONS

CLINICAL | PHARMA

Co-founders Dr. Mark Kiel and Steve Schwartz describe how to harness the power of comprehensive evidence-based data for use in clinical workflows and drug discovery.

Watch the recording

MASTERMIND MASTERCLASS: SENSITIVITY & SPECIFICITY IN GENOMIC SEARCH

CLINICAL | PHARMA

Co-founders Dr. Mark Kiel and Steve Schwartz discuss how Mastermind optimizes specificity and then sensitivity when searching for insight into patient variants and resolving VUSs for optimal diagnostic yield. 

Watch the recording

BIG DATA FOR RARE DISEASE: COMPREHENSIVE GENOMIC LANDSCAPES TO ACCELERATE DRUG DEVELOPMENT

PHARMA

Dr. Mark Kiel uses real-world examples to demonstrate how Mastermind Genomic Landscapes have empowered pharmaceutical researchers and translational teams to understand rare diseases at the molecular level.

Watch the recording

MASTERMIND MASTERCLASS: ACMG/AMP CLASSIFICATION

CLINICAL

Co-founders Dr. Mark Kiel and Steve Schwartz lead a live discussion and demonstration of the ACMG/AMP filtering process in the Mastermind Genomic Search Engine.

Watch the recording

INCREASING CASE THROUGHPUT WITH IMMEDIATE INSIGHT INTO CLINICALLY RELEVANT EVIDENCE

CLINICAL

Congenica’s Helen Savage and Dr. Mark Kiel reveal how a combination of new tools is enabling you to instantly identify and analyze genetic evidence found across the complete corpus of scientific articles.

Watch the recording

COMPREHENSIVE GENOMIC ASSOCIATION DATA FOR GENETIC VARIANT INTERPRETATION

CLINICAL | PHARMA

At this LabRoots Virtual Event, Dr. Mark Kiel presented how Genomenon’s approach to Big Data and Artificial Intelligence allow the variant scientist to understand genomic associations across the entirety of the empirical evidence from the medical literature.

Visit LabRoots to watch on demand

MASTERMIND MASTERCLASS: THERAPIES

CLINICAL

The Mastermind Genomic Search Engine now includes the ability to search the genomic literature by therapy. Co-founders Dr. Mark Kiel and Steve Schwartz led a virtual guided tour of the new Therapies search feature and live Q&A.

Watch the recording

GAINING INSIGHT INTO KNOWN AND NOVEL THERAPIES TO DRIVE DRUG DISCOVERY

PHARMA

Dr. Mark Kiel demonstrates how therapeutic associations between diseases, genes, variants, and phenotypes are a powerful tool in drug development.

Watch the recording

MASTERMIND MASTERCLASS: HUMAN PHENOTYPE ONTOLOGY

CLINICAL

With the release of version 2.0, the Mastermind Genomic Search Engine now includes the ability to search the genomic literature by phenotype. Co-founders Dr. Mark Kiel and Steve Schwartz lead a virtual guided tour of the new HPO search feature and live Q&A.

Watch the recording

USING GENOMICS TO ACCELERATE DRUG DEVELOPMENT FOR NEURODEGENERATIVE DISEASES

PHARMA

In this webinar, Dr. Mark Kiel uses real-world examples to demonstrate how a Comprehensive Genomic Landscape for a disease, pathway or gene set has empowered Pharmaceutical researchers and translational teams to understand genetic and rare diseases at the molecular level.

Watch the recording

GENOMIC LANDSCAPES: LEVERAGING GENETIC EVIDENCE THROUGHOUT THE PHARMA PIPELINE

PHARMA

At the 2020 LabRoots Genetics Virtual Week, Dr. Mark Kiel presented how Genomenon provides invaluable insight into the genomic drivers of disease and an understanding of the molecular drivers that influence all aspects of the drug development pipeline.

Visit LabRoots to watch on demand

RADY CHILDREN’S INSTITUTE FOR GENOMIC MEDICINE – ASHG 2019 COLAB

CLINICAL

At the 2019 American Society of Human Genetics (ASHG) Annual Meeting, Dr. Kasia Ellsworth of Rady Children’s Institute for Genomic Medicine presented at the Genomenon CoLab Session: “Automated Literature Curation and Variant Interpretation Pipelines with Mastermind following rWGS within the Pediatric ICU – the RCIGM Experience”.

Watch presentation

UNIVERSITY OF PITTSBURGH MEDICAL CENTER – ASHG 2019 COLAB

CLINICAL

At the 2019 American Society of Human Genetics (ASHG) Annual Meeting, Dr. Daniel Bellissimo of the University of Pittsburgh Medical Center Clinical Genomics Laboratory presented at the Genomenon CoLab Session: “Mastermind: Advanced Literature Searching to Aid Variant Classification”.

Watch presentation

HOW TO LEVERAGE THE GENOMIC LANDSCAPE TO ACCELERATE PRECISION MEDICINE

PHARMA

Realizing the promise of Precision Medicine requires both a deep understanding of the genomic evidence and an understanding of the molecular drivers that influence the drug development pipeline. In this webinar, Founder & CSO Dr. Mark Kiel discussed the vital role that genomics plays in the pharmaceutical development process.

Watch the recording

3 SIMPLE STEPS TO DIAGNOSE RARE DISEASES IN MINUTES

CLINICAL

Drs. Cyrielle Kint from Diploid and Mark Kiel from Genomenon introduce us to Moon and demonstrate how the integration with Mastermind allows you to easily assess related variants that have been reported in literature.

View the Q&A

DRUG DISCOVERY IN THE AGE OF GENOMICS

CLINICAL | PHARMA

Currently, only 10% of drug therapies actually reach patients because the genetic mechanisms of disease and their consequences for drug action are not well understood. In this webinar, genomics experts Drs. Mark Kiel and Alex Joyner describe the deep and invaluable connection between therapeutics development and genomics, and how to obtain and use NGS data to improve outcomes.

Watch the recording

REAL-WORLD EXAMPLES OF EFFICIENCY IN GAINS IN THE ANALYSIS & INTERPRETATION OF GENOMIC DATA

CLINICAL

In this webinar, Dr. Mark Kiel welcomed our guest Dr. Eva Serra, who demonstrated Congenica, a way to overcome challenges in the analysis, interpretation and reporting of complex genomic data with an all-in-one solution that optimizes process efficiency from raw data to report.

Watch the recording

MAPPING THE GENOMIC LANDSCAPE TO ACCELERATE PRECISION DRUG DEVELOPMENT

CLINICAL | PHARMA

Rhythm Pharmaceuticals and Genomenon discuss their efforts to assemble a database of mutations associated with rare genetic disorders of obesity, and how this was optimized to facilitate a deep understanding of the variant landscape of melanocortin-4 receptor (MC4R)-pathway genes.

Watch the recording

MINING GENOMIC LITERATURE FOR VARIANT INTERPRETATION AND GENE PANEL DESIGN

CLINICAL

Watch an expert panel discuss how they used the new Mastermind Genomic Search Engine to mine the full text of the genomic literature for two key applications: variant interpretation and the development of evidence-based diagnostic gene panels.

Watch the recording

CHARACTERIZING TARGETED CANCER THERAPIES VIA A COMPREHENSIVE GENE FUSION DATABASE

CLINICAL | PHARMA

Genomenon has developed the most comprehensive database of gene fusion pairs found within the scientific literature. This complete literature catalogue for the 507 genes from the Illumina TruSight RNA Fusion Panel contains all known fusion pairs, with reference citations for every scholarly paper citing the chimeric genes.

Watch the recording

ACCELERATING PATIENT DIAGNOSIS WITH AUTOMATED LITERATURE CURATION FOR INHERITED DISEASE

CLINICAL | PHARMA

Dr. Mark Kiel and Veritas Genetics VP of Clinical Affairs Birgit Funke discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.

Watch the recording

IS GENOMIC MEDICINE READY FOR AI?

CLINICAL | PHARMA

Genome sequencing promises to improve diagnostic accuracy and patient outcomes in both oncology and genetics, but the volume and complexity of the data requires a significant manual process to ensure high-quality interpretation. Dr. Mark Kiel offers insight on Artificial Intelligence and its impact on Genomic Medicine.

Watch the recording

AUTOMATED BIOMARKER SELECTION FOR EVIDENCE-BASED GENE PANEL DESIGN

CLINICAL

Dr. Mark Kiel presents the biomarker selection process and results for the first comprehensive evidence-based Pan-Hematopoietic Malignancy Gene Panel using the Mastermind Genomic Search Engine.

Watch the recording

Have questions about Genomenon? Let’s talk!